Acar Ömer, Şanlı Öner
School of Medicine, Department of Urology, Koc University, Istanbul, Turkey.
Istanbul Faculty of Medicine, Department of Urology, Istanbul University, Istanbul, Turkey.
Surg Res Pract. 2016;2016:2394942. doi: 10.1155/2016/2394942. Epub 2016 Jan 26.
Surgical resection either in the form of radical nephrectomy or in the form of partial nephrectomy represents the mainstay options in the treatment of kidney cancer. In most instances, resecting the tumor bearing kidney or the tumor itself provides durable cancer specific survival rates. However, recurrences may rarely develop in the renal fossa or remnant kidney. Despite its rarity, locally recurrent RCC is a challenging condition in terms of the possible management options and relatively poor prognosis. If technically feasible, wide surgical excision and ensuring negative surgical margins are the most effective treatment options. Repeat surgeries (completion nephrectomy, excision of locally recurrent tumor, or repeat partial nephrectomy) may often be complicated, and perioperative morbidity is a major concern. Open approach has been extensively applied in this context and 5-year cancer specific survival rates have been reported to be around 50%. The roles of minimally invasive surgical options (laparoscopic and robotic approach) and nonsurgical alternatives (cryoablation, radiofrequency ablation) have yet to be described. In selected patients, surgical resection may have to be complemented with (neo)adjuvant radiotherapy or medical treatment.
手术切除,无论是根治性肾切除术还是部分肾切除术,都是肾癌治疗的主要选择。在大多数情况下,切除患肾或肿瘤本身可提供持久的癌症特异性生存率。然而,复发可能很少发生在肾窝或残余肾脏。尽管罕见,但局部复发性肾细胞癌在可能的治疗选择和相对较差的预后方面是一个具有挑战性的情况。如果技术可行,广泛的手术切除并确保手术切缘阴性是最有效的治疗选择。重复手术(根治性肾切除术、局部复发性肿瘤切除术或重复部分肾切除术)通常可能很复杂,围手术期发病率是一个主要问题。开放手术已在这种情况下广泛应用,据报道5年癌症特异性生存率约为50%。微创外科手术选择(腹腔镜和机器人手术)和非手术替代方案(冷冻消融、射频消融)的作用尚未得到描述。在选定的患者中,手术切除可能必须辅以(新)辅助放疗或药物治疗。